Generic, Branded Generic & Proprietary Medicinal Products – Group 11
Details
- Supplier(s)
35 suppliers
- AVENTIS PHARMA LIMITED
- Abbvie Ltd
- Aguettant Ltd
- Astra Zeneca UK Limited
- Bayer Public Limited Company
- Chiesi Ltd
- Colonis Pharma Limited
- Dr Falk Pharma UK Ltd
- Dr Reddy's Laboratories (UK) Ltd
- Ferring Pharmaceutical
- Focus Pharmaceuticals Ltd
- FRESENIUS KABI LIMITED
- Galen Ltd
- GLAXOSMITHKLINE UK LIMITED
- Glenmark Pharmaceuticals Europe Ltd
- Grunenthal Ltd
- Hameln Pharma Ltd
- Janssen Cilag Ltd
- Kent Pharma (UK) Ltd
- Macure Pharma UK Ltd
- Martindale Pharma
- Mercury Pharmaceuticals Ltd
- Morningside Pharmaceuticals Ltd
- Napp Pharmaceuticals
- Neon Healthcare Ltd
- Neuraxpharm UK Ltd
- Novartis UK
- Pfizer Liimted
- Roche Products Ltd
- Sandoz
- Sunovion Pharmaceuticals Europe Ltd
- Teva UK Ltd
- Tillomed Laboratories Ltd
- Tillotts Pharma UK Ltd
- Viatris UK Healthcare Ltd
- Value
- GBP 24,389,705.3
- Topic
- Pharmaceutical products
- Published
- 17 April 2023
- Source
- eu:ted
Tender description
Generic, Branded Generic & Proprietary Medicinal Products – Group 11 Lot 1: Generic, Branded Generic & Proprietary Medicinal Products – Group 11 [4229695] is established under the Medicinal Products Dynamic Purchasing System [131864]. The contract is awarded on behalf of the following contract participants: (i) Belfast Health and Social Care Trust (BHSCT); (ii) South Eastern Health and Social Care Trust (SEHSCT); (iii) Northern Health and Social Care Trust (NHSCT); (iv) Southern Health and Social Care Trust (SHSCT); (v) Western Health and Social Care Trust (WHSCT); (vi) Northern Ireland Ambulance Service (NIAS); (vii) Northern Ireland Blood Transfusion Service (NIBTS); (viii) Business Services Organisation (BSO); (ix) Public Health Agency (PHA); (x) Department of Health, Northern Ireland (DoH(NI)); (xi) Health and Social Care Board (HSCB) (now Strategic Planning and Performance Group). The estimated total value of contract (excluding VAT) is GBP 24 000 000 to GBP 120 000 000. This maximum value in the range takes into consideration and accounts for all available extension provision as outlined in the SS17bc Commercial Conditions of Contract for Supplies Contracts document and provides for potential growth of up to 50% over the course of the contract.
Timeline
- Completed: Award published17 April 2023Current notice
- Completed: Award date17 April 2023
About the buyer
HSC Business Services Organisation is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.
Relevant CPV codes
- 33600000 · Pharmaceutical products
Decision makers
Connect with the people behind this procurement.
| Contact name | Job title | Phone number | Work email |
|---|---|---|---|
| Head of Procurement | +44 •••• •••••• | ••••••••@hsc-business-services-organisation.gov | |
| Commercial Director | +44 •••• •••••• | ••••••••@hsc-business-services-organisation.gov | |
| Procurement Manager | +44 •••• •••••• | ••••••••@hsc-business-services-organisation.gov | |
| Category Lead | +44 •••• •••••• | ••••••••@hsc-business-services-organisation.gov | |
| Senior Buyer | +44 •••• •••••• | ••••••••@hsc-business-services-organisation.gov | |
| Contracts Manager | +44 •••• •••••• | ••••••••@hsc-business-services-organisation.gov |
6 similar open tenders
See more open tenders related to Generic, Branded Generic & Proprietary Medicinal Products – Group 11.
- Open tender
IMP Manufacture, Labelling and Packaging DPS
- Open tender
CPH037 - Enhanced Services (Pharmacies)
- Open tender
Potassium iodide tablets 2024-2026
Related buyers
Buyers similar to HSC Business Services Organisation.
- 112£794.4m
- 18£169.3m
- 12£24.3m
- 3£4.4m
- 514£239.2m
- 382£5.3bn
- 321£279.9m
- 262£44.9m
- 249£141.9m
- 231£25.7m
Win more public sector contracts
Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.
